Investor’s Alert: Yingli Green Energy (NYSE:YGE), SunPower Corporation (NASDAQ:SPWR), Altera Corporation (NASDAQ:ALTR), Cirrus Logic (NASDAQ:CRUS)
Yingli Green Energy Holding Co. Ltd. (ADR) (NYSE:YGE), the largest solar-panel maker, will sell 25 million shares at a 17 percent discount as it raises money to build power plants. The American depositary receipts, which represent one ordinary share, will be sold for $3.50 apiece, the Baoding, China-based company said in a statement today. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) stock performance was … Continue reading Investor’s Alert: Yingli Green Energy (NYSE:YGE), SunPower Corporation (NASDAQ:SPWR), Altera Corporation (NASDAQ:ALTR), Cirrus Logic (NASDAQ:CRUS)
Biotech Early Movers: OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI), Agenus Inc(NASDAQ:AGEN), Athersys, Inc.(NASDAQ:ATHX)
OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) shares plunged more than 48% pre-market after the company said results from its Phase 3 SYNERGY trial to add custirsen to standard first-line treatment of docetaxel/prednisone in men with metastatic prostate cancer failed to meet primary endpoints. The stock which was halted from trading ahead of the news, recently changed hands at $5.00, off an earlier low of $4.25. The shares … Continue reading Biotech Early Movers: OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI), Agenus Inc(NASDAQ:AGEN), Athersys, Inc.(NASDAQ:ATHX)
Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Enzymotec Ltd (NASDAQ:ENZY) Conclude Final Patent Infringement Settlement
Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Acasti Pharma Inc (NASDAQ:ACST), a Neptune subsidiary, Sunday night announced that a final and binding patent infringement settlement and license agreement has been signed with Enzymotec Ltd. and Enzymotec Ltd(NASDAQ:ENZY) that resolves the International Trade Commission’s investigation of infringement of Neptune’s composition of matter patents, related federal court actions initiated by Neptune against Enzymotec and its distributors, and various patent review … Continue reading Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Enzymotec Ltd (NASDAQ:ENZY) Conclude Final Patent Infringement Settlement
Biotech Pre-Market Movers: Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), Synergy Pharmaceuticals Inc(NASDAQ:SGYP), Pfizer Inc.(NYSE:PFE), AstraZeneca plc (ADR)(NYSE:AZN)
The American Despositary Receipts of Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) edged up in recent pre-market trading on Monday after announcing over the weekend an agreement it has signed with Takeda Pharmaceutical for the marketing and sale of Rasagiline in Japan. Rasagiline is a treatment for Parkinson’s Disease developed by TEVA and has been approved in over 40 countries. TEVA closed at $48.69 on Friday in … Continue reading Biotech Pre-Market Movers: Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), Synergy Pharmaceuticals Inc(NASDAQ:SGYP), Pfizer Inc.(NYSE:PFE), AstraZeneca plc (ADR)(NYSE:AZN)
Tech Stocks in the News: Apple Inc.(NASDAQ:AAPL), Google, Inc.(NASDAQ:GOOGL)
Apple Inc.(NASDAQ:AAPL) is offering a program to replace faulty iPhone 5 sleep/wake buttons free of charge, the Wall Street Journal reports. The program is being offered for iPhone 5 handsets built before April 2013. Analysts have a consensus price target of $593 on Apple Inc.(NASDAQ:AAPL) which indicates a 14% upside. The consensus rating of the stock is a BUY with a score of 2.71. There are … Continue reading Tech Stocks in the News: Apple Inc.(NASDAQ:AAPL), Google, Inc.(NASDAQ:GOOGL)
AstraZeneca plc (ADR)(NYSE:AZN) Shares Soar Pre-Market
Shares of AstraZeneca plc (ADR)(NYSE:AZN) reached a new high in pre-market trading as Pfizer Inc.(NYSE:PFE) confirmed it has attempted to renew negotiations on a possible merger. Pfizer submitted a preliminary indication of interest to the board of directors of AstraZeneca in January 2014 regarding the possible merger. AstraZeneca declined to pursue negotiations at that time, but Pfizer contacted AstraZeneca on April 26, 2014, seeking to renew … Continue reading AstraZeneca plc (ADR)(NYSE:AZN) Shares Soar Pre-Market